Is Now The Time To Put FNS TECH (KOSDAQ:083500) On Your Watchlist?

Investors are often guided by the idea of discovering ‘the next big thing’, even if that means buying ‘story stocks’ without any revenue, let alone profit. Unfortunately, these high risk investments often have little probability of ever paying off, and many investors pay a price to learn their lesson. Loss-making companies are always racing against time to reach financial sustainability, so investors in these companies may be taking on more risk than they should.

Despite being in the age of tech-stock blue-sky investing, many investors still adopt a more traditional strategy; buying shares in profitable companies like FNS TECH (KOSDAQ:083500). While this doesn’t necessarily speak to whether it’s undervalued, the profitability of the business is enough to warrant some appreciation – especially if its growing.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.

FNS TECH’s Earnings Per Share Are Growing

If you believe that markets are even vaguely efficient, then over the long term you’d expect a company’s share price to follow its earnings per share (EPS) outcomes. Therefore, there are plenty of investors who like to buy shares in companies that are growing EPS. Shareholders will be happy to know that FNS TECH’s EPS has grown 22% each year, compound, over three years. If the company can sustain that sort of growth, we’d expect shareholders to come away satisfied.

It’s often helpful to take a look at earnings before interest and tax (EBIT) margins, as well as revenue growth, to get another take on the quality of the company’s growth. The good news is that FNS TECH is growing revenues, and EBIT margins improved by 4.4 percentage points to 14%, over the last year. That’s great to see, on both counts.

The chart below shows how the company’s bottom and top lines have progressed over time. For finer detail, click on the image.

See our latest analysis for FNS TECH

Since FNS TECH is no giant, with a market capitalisation of ₩113b, you should definitely check its cash and debt before getting too excited about its prospects.

Are FNS TECH Insiders Aligned With All Shareholders?

Theory would suggest that it’s an encouraging sign to see high insider ownership of a company, since it ties company performance directly to the financial success of its management. So we’re pleased to report that FNS TECH insiders own a meaningful share of the business. Actually, with 37% of the company to their names, insiders are profoundly invested in the business. Those who are comforted by solid insider ownership like this should be happy, as it implies that those running the business are genuinely motivated to create shareholder value. With that sort of holding, insiders have about ₩41b riding on the stock, at current prices. That should be more than enough to keep them focussed on creating shareholder value!

Should You Add FNS TECH To Your Watchlist?

You can’t deny that FNS TECH has grown its earnings per share at a very impressive rate. That’s attractive. This EPS growth rate is something the company should be proud of, and so it’s no surprise that insiders are holding on to a considerable chunk of shares. The growth and insider confidence is looked upon well and so it’s worthwhile to investigate further with a view to discern the stock’s true value. You should always think about risks though. Case in point, we’ve spotted 3 warning signs for FNS TECH you should be aware of.

Although FNS TECH certainly looks good, it may appeal to more investors if insiders were buying up shares. If you like to see companies with more skin in the game, then check out this handpicked selection of South Korean companies that not only boast of strong growth but have strong insider backing.

Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.